Repetitive transcranial magnetic stimulation for treatment-resistant depression: A systematic review and meta-analysis

Journal of Clinical Psychiatry

Volumn 75, Issue 5, 2014, Pages 477-489

  Gaynes, Bradley N ^a,b   Lloyd, Stacey W ^c   Lux, Linda ^c   Gartlehner, Gerald ^c,d   Hansen, Richard A ^e   Brode, Shannon ^b,f   Jonas, Daniel E ^a,b   Evans, Tammeka Swinson ^c   Viswanathan, Meera ^c   Lohr, Kathleen N ^c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c RTI INTERNATIONAL   (United States)

^d DANUBE UNIVERSITY KREMS   (Austria)

^e AUBURN UNIVERSITY   (United States)

^f HAYES Plus Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ARTICLE; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL (TOPIC); DISEASE SEVERITY; DRUG TREATMENT FAILURE; EFFECT SIZE; EVIDENCE BASED MEDICINE; HAMILTON SCALE; HUMAN; INTERNAL VALIDITY; MAJOR DEPRESSION; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PUBLISHING; QUALITY CONTROL; REMISSION; REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION; RISK BENEFIT ANALYSIS; SAMPLE SIZE; SYSTEMATIC REVIEW; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT DURATION; TREATMENT RESISTANT DEPRESSION; TREATMENT RESPONSE;

DEPRESSIVE DISORDER, MAJOR; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; HUMANS; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84901711326     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.13r08815     Document Type: Article

References (61)

1. Kessler RC, Berglund P, Demler O, et al National Comorbidity Survey Replication. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289(23):3095-3105. (Pubitemid 37432885
2. Wang PS, Lane M, Olfson M, et al; Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):629-640. (Pubitemid 40973438
3. Trivedi MH, Rush AJ, Wisniewski SR, et al; STAR*D Study Team. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR D: implications for clinical practice. Am J Psychiatry. 2006;163(1):28-40. (Pubitemid 43050100)
4. Thase ME, Rush AJ. When at first you don't succeed: sequential strategies for antidepressant nonresponders. J Clin Psychiatry. 1997;58(suppl 13):23-29. (Pubitemid 28011969
5. Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163(11):1905-1917. (Pubitemid 44807782
6. Berlim MT, Fleck MP, Turecki G. Current trends in the assessment and somatic treatment of resistant/refractory major depression: an overview. Ann Med. 2008;40(2):149-159. (Pubitemid 351640642
7. Berlim MT, Turecki G. What is the meaning of treatment resistant/refractory major depression (TRD)? A systematic review of current randomized trials. Eur Neuropsychopharmacol. 2007;17(11):696-707. (Pubitemid 47422400
8. Gaynes BN. Identifying difficult-to-treat depression: differential diagnosis, subtypes, and comorbidities. J Clin Psychiatry. 2009;70(suppl 6):10-15.
9. Russell JM, Hawkins K, Ozminkowski RJ, et al. The cost consequences of treatment-resistant depression. J Clin Psychiatry. 2004;65(3):341-347.
10. Gartlehner G, Gaynes BN, Hansen RA, et al. Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians. Ann Intern Med. 2008;149(10):734-750.
11. Berlim MT, van den Eynde F, Tovar-Perdomo S, et al. Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials. Psychol Med. 2014;44(2):225-239.
12. American Psychiatric Association. Practice Guideline for the Treatment of Patients With Major Depressive Disorder. 3rd ed. Washington, DC: American Psychiatric Association; 2010.
13. Melkerson MN. Special Premarket 510(k) Notification for NeuroStar TMS Therapy System for Major Depressive Disorder. 2008. http://www.accessdata.fda. gov/cdrh-docs/pdf8/K083538.pdf. Updated December 16, 2008. Accessed March 19, 2014.
14. FDA. 510(K) Summary Brainsway Deep TMS System. July 10, 2012. www.accessdata.fda.gov/cdrh-docs/pdf12/K122288.pdf. Updated January 7, 2013. Accessed March 19, 2014.
15. Appleby J. Magnetic stimulation helps some people with treatment-resistant depression. Washington Post. August 6, 2012: E1.
16. The New England Comparative Effectiveness Public Advisory Council. Treatment Options for Treatment-Resistant Depression: Repetitive Transcranial Magnetic Stimulation. 2012. http://cepac.icer-review.org/wp-content/uploads/ 2011/04/rTMS-Coverage-Policy-Analysis.pdf. Accessed March 14, 2014.
17. Gaynes BN, Lux L, Lloyd S, et al. KN L. Nonpharmacologic Interventions for Treatment-Resistant Depression in Adults. Comparative Effectiveness Review No. 33. Rockville, MD: Agency for Healthcare Research and Quality; 2011.
18. US Preventive Services Task Force. US Preventive Services Task Force Grade Definitions. 2008: http://www.uspreventiveservicestaskforce.org/uspstf/ grades.htm. Accessed March 19, 2014.
19. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56-62.
20. Sterne JAC, Sutton AJ, Ioannidis JPA, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011;343(1):d4002.
21. Owens DK, Lohr KN, Atkins D, et al. AHRQ series paper 5: grading the strength of a body of evidence when comparing medical interventions - agency for healthcare research and quality and the effective health-care program. J Clin Epidemiol. 2010;63(5):513-523.
22. Bakim B, Uzun UE, Karamustafalioglu O, et al. The combination of antidepressant drug therapy and high-frequency repetitive transcranial magnetic stimulation in medication-resistant depression. Klinik Psikofarmakoloji Bulteni. 2012;22(3):244-253.
23. Boutros NN, Gueorguieva R, Hoffman RE, et al. Lack of a therapeutic effect of a 2-week sub-threshold transcranial magnetic stimulation course for treatment-resistant depression. Psychiatry Res. 2002;113(3):245-254. (Pubitemid 36136047
24. Garcia-Toro M, Mayol A, Arnillas H, et al. Modest adjunctive benefit with transcranial magnetic stimulation in medication-resistant depression. J Affect Disord. 2001;64(2-3):271-275. (Pubitemid 32324221
25. Garcia-Toro M, Salva J, Daumal J, et al. High (20-Hz) and low (1-Hz) frequency transcranial magnetic stimulation as adjuvant treatment in medication-resistant depression. Psychiatry Res. 2006;146(1):53-57. (Pubitemid 43269988
26. Kauffmann CD, Cheema MA, Miller BE. Slow right prefrontal transcranial magnetic stimulation as a treatment for medication-resistant depression: a double-blind, placebo-controlled study. Depress Anxiety. 2004;19(1):59-62. (Pubitemid 38294610
27. Padberg F, Zwanzger P, Thoma H, et al. Repetitive transcranial magnetic stimulation (rTMS) in pharmacotherapy-refractory major depression: comparative study of fast, slow and sham rTMS. Psychiatry Res. 1999;88(3):163-171. (Pubitemid 30074173
28. Pallanti S, Bernardi S, Di Rollo A, et al. Unilateral low frequency versus sequential bilateral repetitive transcranial magnetic stimulation: is simpler better for treatment of resistant depression? Neuroscience. 2010;167(2):323-328.
29. Zheng H, Zhang L, Li L, et al. High-Frequency rTMS Treatment Increases Left Prefrontal Myo-Inositol in Young Patients With Treatment-Resistant Depression: Progress in Neuro-Psychopharmacology & Biological Psychiatry. Amsterdam, the Netherlands: Elsevier Science; 2010:1189-1195.
30. Blumberger DM, Mulsant BH, Fitzgerald PB, et al. A randomized doubleblind sham-controlled comparison of unilateral and bilateral repetitive transcranial magnetic stimulation for treatment-resistant major depression. World J Biol Psychiatry. 2012;13(6):423-435.
31. Holtzheimer PE 3rd, Russo J, Claypoole KH, et al. Shorter duration of depressive episode may predict response to repetitive transcranial magnetic stimulation. Depress Anxiety. 2004;19(1):24-30.
32. Avery DH, Holtzheimer PE 3rd, Fawaz W, et al. A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression. Biol Psychiatry. 2006;59(2):187-194 (Pubitemid 43117509
33. Fitzgerald PB, Hoy KE, Herring SE, et al. A double blind randomized trial of unilateral left and bilateral prefrontal cortex transcranial magnetic stimulation in treatment resistant major depression. J Affect Disord. 2012;139(2):193-198.
34. Pascua1-Leone A, Rubio B, Pallardó F, et al. Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression. Lancet. 1996;348(9022):233-237. (Pubitemid 26254198
35. Bocchio-Chiavetto L, Miniussi C, Zanardini R, et al. 5-HTTLPR and BDNF Val66Met polymorphisms and response to rTMS treatment in drug resistant depression. Neurosci Lett. 2008;437(2):130-134.
36. Fitzgerald PB, Brown TL, Marston NA, et al. Transcranial magnetic stimulation in the treatment of depression: a double-blind, placebo-controlled trial. Arch Gen Psychiatry. 2003;60(10):1002-1008. (Pubitemid 37222083
37. Fitzgerald PB, Benitez J, de Castella A, et al. A randomized, controlled trial of sequential bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression. Am J Psychiatry. 2006;163(1):88-94. (Pubitemid 43050108
38. Su T-P, Huang C-C, Wei IH. Add-on rTMS for medication-resistant depression: a randomized, double-blind, sham-controlled trial in Chinese patients. J Clin Psychiatry. 2005;66(7):930-937. (Pubitemid 41032837
39. Triggs WJ, Ricciuti N, Ward HE, et al. Right and left dorsolateral pre-frontal rTMS treatment of refractory depression: a randomized, sham-controlled trial. Psychiatry Res. 2010;178(3):467-474.
40. Manes F, Jorge R, Morcuende M, et al. A controlled study of repetitive transcranial magnetic stimulation as a treatment of depression in the elderly. Int Psychogeriatr. 2001;13(2):225-231. (Pubitemid 32703333
41. Moser DJ, Jorge RE, Manes F, et al. Improved executive functioning following repetitive transcranial magnetic stimulation. Neurology. 2002;58(8):1288-1290. (Pubitemid 34411879
42. Stern WM, Tormos JM, Press DZ, et al. Antidepressant effects of high and low frequency repetitive transcranial magnetic stimulation to the dorsolateral prefrontal cortex: a double-blind, randomized, placebo-controlled trial. J Neuropsychiatry Clin Neurosci. 2007;19(2):179-186. (Pubitemid 46649642
43. O'Reardon JP, Solvason HB, Janicak PG, et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry. 2007;62(11):1208-1216. (Pubitemid 350060890
44. George MS, Lisanby SH, Avery D, et al. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry. 2010;67(5):507-516.
45. Berman RM, Narasimhan M, Sanacora G, et al. A randomized clinical trial of repetitive transcranial magnetic stimulation in the treatment of major depression. Biol Psychiatry. 2000;47(4):332-337. (Pubitemid 30109246
46. Bretlau LG, Lunde M, Lindberg L, et al. Repetitive transcranial magnetic stimulation (rTMS) in combination with escitalopram in patients with treatment-resistant major depression: a double-blind, randomised, sham-controlled trial. Pharmacopsychiatry. 2008;41(2):41-47. (Pubitemid 351427521
47. Bortolomasi M, Minelli A, Fuggetta G, et al. Long-lasting effects of high frequency repetitive transcranial magnetic stimulation in major depressed patients. Psychiatry Res. 2007;150(2):181-186. (Pubitemid 46386292
48. George MS, Wassermann EM, Kimbrell TA, et al. Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: a placebo-controlled crossover trial. Am J Psychiatry. 1997;154(12):1752-1756. (Pubitemid 27516596
49. Möller AL, Hjaltason O, Ivarsson O, et al. The effects of repetitive transcranial magnetic stimulation on depressive symptoms and the P(300) event-related potential. Nord J Psychiatry. 2006;60(4):282-285. (Pubitemid 44264031
50. National Institute for Clinical Excellence. Depression: Management of Depression in Primary and Secondary Care. Clinical Practice Guideline No. 23. London, UK: National Institute for Clinical Excellence; 2004.
51. Spielmans GI, Berman MI, Linardatos E, et al. Adjunctive atypical antipsychotic treatment for major depressive disorder: a meta-analysis of depression, quality of life, and safety outcomes. PLoS Med. 2013;10(3):e1001403.
52. Lam RW, Chan P, Wilkins-Ho M, et al. Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis. Can J Psychiatry. 2008;53(9):621-631.
53. Berlim MT, Van den Eynde F, Jeff Daskalakis Z. Clinically meaningful efficacy and acceptability of low-frequency repetitive transcranial magnetic stimulation (rTMS) for treating primary major depression: a meta-analysis of randomized, double-blind and sham-controlled trials. Neuropsychopharmacology. 2013;38(4):543-551.
54. Berlim MT, Van den Eynde F, Daskalakis ZJ. A systematic review and meta-analysis on the efficacy and acceptability of bilateral repetitive transcranial magnetic stimulation (rTMS) for treating major depression. Psychol Med. 2013;43(11):2245-2254.
55. Lisanby SH, Husain MM, Rosenquist PB, et al. Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial. Neuropsychopharmacology. 2009;34(2):522-534.
56. George MS, Aston-Jones G. Noninvasive techniques for probing neurocircuitry and treating illness: vagus nerve stimulation (VNS), transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS). Neuropsychopharmacology. 2010;35(1):301-316.
57. Wassermann EM, Zimmermann T. Transcranial magnetic brain stimulation: therapeutic promises and scientific gaps. Pharmacol Ther. 2012;133(1):98-107.
58. Belmaker B, Fitzgerald P, George MS, et al. Managing the risks of repetitive transcranial stimulation. CNS Spectr. 2003;8(7):489. (Pubitemid 38418381
59. Lee JC, Blumberger DM, Fitzgerald PB, et al. The role of transcranial magnetic stimulation in treatment-resistant depression: a review. Curr Pharm Des. 2012;18(36):5846-5852.
60. Rossi S, Hallett M, Rossini PM, et al Safety of TMS Consensus Group. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 2009;120(12):2008-2039.
61. Berlim MT, Broadbent HJ, Van den Eynde F. Blinding integrity in randomized sham-controlled trials of repetitive transcranial magnetic stimulation for major depression: a systematic review and meta-analysis. Int J Neuropsychopharmacol. 2013;16(5):1173-1181.